{'text': "European Commission Approves Amgen's BLINCYTO® (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia", 'publisher': {'href': 'https://www.amgen.com', 'title': 'Amgen'}, 'created_at': 'Mon, 23 Nov 2015 08:00:00 GMT', 'description': "European Commission Approves Amgen's BLINCYTO® (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia  Amgen", 'url': 'https://news.google.com/rss/articles/CBMi2wJBVV95cUxPRktzQmpWbHV4RjgwT3luTjc3R3BUNktEbjQ3WlE1VlZZTXdXalhVRzN6MHkzMVozN3drQ3ZIZ1BRV2lDTkxwRm5pQjdpdE5pMi1HN3VOT1FpUDM3MEY3U3Q0TnlGaVRSZ2liY2NibDc1OWVvVEFqOGkxMk1hWlNJTkI3U3MtbEhjZkc0Q0NJMjdIeVV5MUJTTnVQTEM1WE4wMzFVV29sX2FjN1UtenVBNndWRlRGWmU3cGFOWU8xNG54Nk9MQmc4c2VxdUFGMDhXbGZ6RFBiTk5wNFFqQ0w0STA1ZmVhRGhoQk9MRjFJcUpSaEhSc0E0OTZKSVgyWkl2cjBwaE1XUm80bjNoSmM1VVJ0NDJjanRFOHphZlFaRjktcmRiNFRwNjFxSThSb25mQjJvN1o5LVY5TGZRRUdSYkFRZVlFbHdBMUlxRVc4Uy10UXdScHo4dHVtOA?oc=5&hl=en-US&gl=US&ceid=US:en'}
